cyclothiazide

Trade name: anhydron

Small moleculeapproved

Approved

Aug 20, 1963

Cyclothiazide was presumably developed by Eli Lilly for the treatment of hypertension. It is believed that the drug, which belongs to the class of thiazide diuretics, exerts its action by inhibitin sodium reabsorption in the renal tubules. In 1993 it was discovered that cyclothiazide stimulates AMPA receptors thus inducing seizure behavior. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1960s

  1. Aug 20, 1963

    Eli Lilly — Earliest FDA Approval

  2. Aug 20, 1963

    Eli Lilly — NDA Organization

1980s

  1. Jun 8, 1982

    Pharmacia & Upjohn — NDA Secondary Org

Indications

Approved for

Mechanism of action

Approval history

  • approvedAug 20, 1963

Chemistry & pharmacology

Loading structure…

SMILES

NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C3CC4CC3C=C4
Mol. weight
389.878 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 35483
  • 6-chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
  • 6-chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • anhydron
  • anhydron
  • anhydron
  • ciclotiazida
  • ciclotiazida
  • ciclotiazide
  • ciclotiazide
  • ciclotiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazide
  • cyclothiazidum
  • cyclothiazidum
  • fluidil
  • fluidil

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
Eli LillyFor profitNDAAug 20, 1963
Pharmacia & UpjohnFor profitNDA2Jun 8, 1982